Clene to Current at Upcoming October Conferences By Investing.com

SALT LAKE CITY, Oct. 09, 2024 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (together with its subsidiaries, Clene) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical firm centered on enhancing mitochondrial well being and defending neuronal operate to deal with neurological illnesses, together with amyotrophic lateral sclerosis (ALS) and a number of sclerosis (MS), in the present day introduced that it’ll take part within the following investor conferences in October.

2024 Maxim Healthcare Digital Summit
Date: October 15-17, 2024
Location: Digital
Presentation: October 15, 2024, at 2:30 p.m. E.T.
Format: Hearth Presentation and 1×1 conferences
Attendance: Signal as much as develop into an M-Vest member

The ThinkEquity Convention 2024
Dates: October 30, 2024
Location: New York, New York, Mandarin Oriental Resort
Presentation: October 30, 2024, at 3:30 p.m. E.T.
Format: Presentation and 1×1 conferences
Webcast Hyperlink: https://wsw.com/webcast/tep25/clnn/1673136

About Clene
Clene Inc., (Nasdaq: CLNN) (together with its subsidiaries, Clene) and its wholly owned subsidiary Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical firm centered on enhancing mitochondrial well being and defending neuronal operate to deal with neurodegenerative illnesses, together with amyotrophic lateral sclerosis, Parkinson’s illness, and a number of sclerosis. CNM-Au8 ® is an investigational first-in-class remedy that improves central nervous system cells’ survival and performance through a mechanism that targets mitochondrial operate and the NAD pathway whereas lowering oxidative stress. CNM-Au8 ® is a federally registered trademark of Clene Nanomedicine, Inc. The corporate relies in Salt Lake Metropolis, Utah, with R&D and manufacturing operations in Maryland. For extra data, please go to www.clene.com or comply with us on X (previously Twitter) and LinkedIn.

Contacts:

Supply: Clene Inc.